In addition to the routine treatment ( metformin ) , patients will receive a second drug orally for 12 weeks : the METV group will receive metformin plus vildagliptin ( 50 mg twice daily ) , and the METG group will receive metformin plus glibenclamide ( 5 to 10 mg twice daily . )